BeNeLuxBelgiumNetherlandsLuxembourg

Tools of Science opens gates

01.10.2011

Brussels – A European gateway to life science capacities has been launched (www.toolsofscience.eu) that is aimed at providing a novel resource for identifying the best facilities and service companies from among 13 bioregions across Europe. National and regional financing opportunities to support R&D projects in life science companies are featured, as well as guidelines and useful links to collaboration tools. Tools of Science provides an easy way to identify the right partner for scientific services. It currently displays around 200 entries, with a number of bioregions on the waiting list. Researchers and entrepreneurs can navigate in the database structure using keywords or categ­ories such as region, development phase or specific field of science. There are also guidelines and templates for facility-sharing and information on funding opportunities available as downloads at the portal. The gateway was developed within the scope of the EU-funded ABC Europe project (2009-2012), which brings together 13 life science clusters in Europe – amongst them Wallonia’s BIOWIN, Britain’s One Nucleus and French clusters Medicen and Alsace Biovalley. Supported by the Council of European Bio­regions, the overall aim of ABC Europe is to internationalise life science SMEs, bringing together clusters across the continent.

Politics / Law

06.03.2012

The human race is at war with another species, and has been for thousands of years. Each of us in Europe swats dead dozens of the enemy every summer, and in the tropics they kill thousands of people with infectious diseases...

Tech Review

06.03.2012

The Philogen group is a specialist for therapies against cancer. Unlike other private companies, the Swiss-Italian firm has developed a rich pipeline of antibodies consisting of five different molecules being tested in 15...

Tech Review

06.03.2012

Success in the biopharmaceutical industry is mainly driven by the ability to innovate, and the continuous development of new products is crucial in that context. Shortening development times is key. The use of comprehensive...

Tech Review

06.03.2012

Zurich-based NeurImmune AG follows unconventional routes – for example, the company doesn’t rely on VC investors. And Neurimmune has also turned the drug discovery process upside down by taking its drug candidates from healthy...

Tech Review

06.03.2012

The use of bispecific antibodies recognising two different targets may allow improvement of clinical efficacy. A bispecific antibody for two growth factors that stimulate the formation of blood vessels – Ang2 (Angiopoietin-2) and...

Clinical Trial

02.03.2012

Sweden’s Karo Bio AB has been hit hard by toxicity issues with its lead compound eprotirome. The anti-cholesterol drug – which was in Phase III clinical development – proved unsafe in a long-term animal tests. The drug lead to...

Clinical Trial

01.03.2012

Inspiration Biopharmaceuticals Inc. reported on 22 February that its lead candidate drug proved successful in a clinical trial involving 12 patients who suffer from hemophilia B. The results were presented at the 5th Annual EAHAD...

Displaying results 21 to 30 out of 1983

< Previous 21-30 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive/browse/2/article/tools-of-science-opens-gates.html

Product of the week

Products

Events

All Events

Current issue

All issues